Skip to main content
. Author manuscript; available in PMC: 2024 Jun 1.
Published in final edited form as: Clin Psychol (New York). 2023 Feb 27;30(2):129–142. doi: 10.1037/cps0000131

Table 5.

Overall Treatment Recommendation for CBT for SUD

Recommendation Criteria
Very strong recommendation All of the following:
  • There is high-quality evidence that the treatment produces a clinically meaningful effect on symptoms of the disorder being treated

  • There is high-quality evidence that the treatment produces a clinically meaningful effect on functional outcomes

  • There is high-quality evidence that the treatment produces a clinically meaningful effect on symptoms and/or functional outcomes at least three months after treatment discontinuation

  • At least one well-conducted study has demonstrated effectiveness in nonresearch settings

Strong recommendation At least one of the following:
  • There is moderate- to high-quality evidence that the treatment produces a clinically meaningful effect on symptoms of the disorder being treated

  • There is moderate- to high-quality evidence that the treatment produces a clinically meaningful effect on functional outcomes

Weak recommendation Any of the following:
  • There is only low- or very low-quality evidence that the treatment produces a clinically meaningful effect on symptoms of the disorder being treated

  • There is only low- or very low-quality evidence that the treatment produces a clinically meaningful effect on as well as on functional outcomes

  • There is moderate- to high-quality evidence that the effect of the treatment, although statistically significant, may not be of a magnitude that is clinically meaningful

Note. This table was adapted from Tolin et al., 2015.